Dr.Reddy's gets one USFDA observation for its Srikakulam formulation plant

“We have been issued a Form 483 with one observation, which we are addressing,” the company said.

June 16, 2017 / 21:52 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Dr.Reddy’s on Friday said it has received Form 483 observation for its formulations plant in Srikakulam .

“The audit of our Formulations Srikakulam Plant (SEZ) Unit 1, Andhra Pradesh, by the US FDA has been completed today,” Dr.Reddy’s said in a statement.

“We have been issued a Form 483 with one observation, which we are addressing,” the company added.

The company didn’t disclose the nature of these observations.

The announcement came after the market hours.

Shares of Dr.Reddy's dropped 0.81 percent to close at Rs.2677.10 on BSE, the benchmark Sensex declined 0.06 percent to end at 31,056.40 points.

first published: Jun 16, 2017 09:52 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347